Amgen Sponsors the Partnership for Safe Medicines Interchange

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in…

[...]

Xuanhao Chan To Speak On Panel at Interchange

Xuanhao Chan, lead technical officer for the International Pharmaceutical Federation, will join panelists on “The role of Patients and Healthcare Professionals” at the Partnership for Safe Medicine Interchange on October 27, 2011.

Chan is a registered pharmacist from Singapore and for the past 6 years, he has been working for the International Pharmaceutical Federation (FIP) in various positions. More recently, in 2008 he established the first branch office for FIP in Geneva managing the Federation’s global public health partnerships and serves as the FIP advocacy focal point with the World Health Organization (WHO) and other international health-related agencies in Geneva, Switzerland.

[...]

Lilly, Sponsor of the Partnership for Safe Medicines Interchange 2011

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs. Learn more about…

[...]

Pfizer, Sponsor of the Partnership for Safe Medicines Interchange

Pfizer applies science and global resources to improve health and well-being at every stage of life. They strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Their diversified global health care portfolio includes human and animal biologic and small molecule medicines and…

[...]

Keynote Speaker Announced for Interchange

John Morton will be the keynote speaker for The Partnership for Safe Medicine’s Interchange on October 27, 2011 at the National Press Club.

Morton is the Director of Immigration and Customs Enforcement (ICE), the principal investigative arm of the U.S. Department of Homeland Security and the second largest investigative agency in the federal government. During his tenure at ICE, he has strengthened ICE’s investigative efforts, with a particular emphasis on border crimes, export controls, intellectual property enforcement and child exploitation.

[...]

Sproxil, Sponsor of the Partnership for Safe Medicines Interchange

Sproxil provides world-class brand protection for emerging markets through software and services that work anywhere there are mobile phones. Delivering automatic protection, simple labels and robust back-end analytics with its Mobile Product AuthenticationTM (MPA) solution, Sproxil offers a comprehensive anti-counterfeiting strategy for cash-based societies, one that enables consumers to text message an item-unique code for…

[...]

Foreign Medicines Poses a Risk to Chronically Ill Americans

The Partnership for Safe Medicines (PSM) released a new report this week, A Risky Proposition: How Opening the U.S. to Foreign Medicines Poses a Risk to Chronically Ill Americans, detailing the dangers posed to American patients by opening up the secure and safe U.S. medical supply chain to foreign drugs through importation.   We released this latest…

[...]

Jeremiah Mwangi, Policy and External Affairs Director of IAPO

Listening to the thought leaders of safe medicinesat the 2010 Interchange Jeremiah Mwangi, Policy and External Affairs Director of International Alliance of Patients’ Organizations (IAPO), will sit on “The Role of Patients and Healthcare Professionals” panel at 1:45pm at the Partnership for Safe Medicine’s Interchange on October 27, 2011 at the National Press Club in…

[...]